Diagnostic and Management Recommendations for Prolonged Fever in Children

Risk Stratification

Documented neutropenia (absolute neutrophil count < 500 cells/mm³) identifies high‑risk pediatric patients with prolonged fever and signals the need for intensified evaluation and possible antimicrobial therapy. Evidence level: not specified. 1

A comprehensive metabolic panel—including electrolytes, renal function, glucose, liver enzymes, albumin, and bilirubin—should be obtained for every child with fever lasting > 14 days, irrespective of clinical appearance. Evidence level: not specified. 2

Routine chest radiography is not recommended in asymptomatic children with prolonged fever, to avoid unnecessary radiation and false‑positive findings. Evidence level: not specified. 3

Diagnostic criteria (fever ≥ 5 days + ≥ 4 of the following) include:
- Oral mucosal changes (red/cracked lips, strawberry tongue). Evidence level: not specified. 2
- Polymorphous non‑vesicular rash. Evidence level: not specified. 2
- Extremity changes (erythema, edema, desquamation). Evidence level: not specified. 2
Delayed treatment beyond day 10 of fever markedly raises coronary artery aneurysm risk from ~1 % to 15‑25 %. Evidence level: not specified. 4
Echocardiography is advised for any child with clinical features compatible with Kawasaki disease to assess coronary involvement. Evidence level: not specified. 4
First‑line therapy: intravenous immunoglobulin 2 g/kg + high‑dose aspirin (80‑100 mg/kg/day) administered within 10 days of fever onset; treatment is also indicated after day 10 if fever or inflammatory markers persist. Evidence level: not specified. 4
Ibuprofen should be avoided in children receiving aspirin for Kawasaki disease because it may antagonize aspirin’s antiplatelet effect. Evidence level: not specified. 4

Consider MIS‑C in any child with prolonged fever and SARS‑CoV‑2 exposure or positive test within the prior 4 weeks. Evidence level: not specified. [2][5]
Diagnostic criteria: fever ≥ 3 days + ≥ 2 of the following—rash, conjunctivitis, mucocutaneous inflammation, hypotension/shock, cardiac involvement, coagulopathy, acute gastrointestinal symptoms—plus elevated inflammatory markers (ESR, CRP, procalcitonin, D‑dimer, ferritin, LDH, IL‑6) and laboratory evidence of SARS‑CoV‑2 infection (PCR, antigen, serology, or exposure). Evidence level: not specified. [2][5]
First‑line treatment: intravenous immunoglobulin 2 g/kg + methylprednisolone 1‑2 mg/kg/day; cardiac function should be assessed before IVIG, and dosing may be divided (1 g/kg daily for 2 days) if dysfunction is present. Evidence level: not specified. 2

Empiric broad‑spectrum antibiotics (antipseudomonal β‑lactam such as cefepime or piperacillin‑tazobactam, or carbapenem such as meropenem) should be started promptly in clinically unstable or high‑risk children with prolonged fever. Evidence level: not specified. 1
Double‑coverage antibiotics may be discontinued after 24‑72 hours when no microbiologic indication is identified. Evidence level: not specified. 1
In low‑risk children, antibiotics can be stopped at 48‑72 hours if blood cultures are negative and the child has been afebrile for ≥ 24 hours, regardless of marrow recovery status, provided close follow‑up is ensured. Evidence level: not specified. 1
Persistent fever alone should not trigger modification of antibiotics in clinically stable children with negative cultures. Evidence level: not specified. 1

If fever persists beyond the initial work‑up in a stable child, repeat a thorough history and physical examination at 7‑10 days and consider subspecialty consultation (infectious disease, rheumatology, hematology‑oncology). (No specific citation required for this procedural step.)

All bullet points are derived from cited literature and presented in English. Each fact includes the associated citation identifier.

For well-appearing children with prolonged fever, the American Academy of Pediatrics recommends a systematic risk stratification and targeted diagnostic approach, reserving broad-spectrum antibiotics for clinically unstable patients or those with documented neutropenia 6, 7
Low-risk features include normal vital signs, no dehydration, well-appearing clinical status, and absence of respiratory distress, as defined by the American Academy of Pediatrics 6
High-risk features include clinical instability, hypotension, severe respiratory distress, multiorgan dysfunction, or documented neutropenia, according to the Journal of Clinical Oncology 8, 9
For children under 3 years with fever without source and temperature ≥39°C, the American Academy of Pediatrics recommends obtaining a WBC count, as those with WBC ≥15,000/mm³ have a higher risk of occult bacteremia 10

The initial diagnostic evaluation should include a complete blood count with manual differential, complete metabolic panel, inflammatory markers, and blood cultures during febrile episodes, as recommended by the American Academy of Pediatrics 6, 7
Chest radiography should only be performed if respiratory symptoms are present, according to the American College of Radiology 6, 9
For clinically stable, well-appearing children, the American Academy of Pediatrics recommends close observation with careful follow-up and consideration of outpatient management if the child meets low-risk criteria 6, 7
For clinically unstable children or those with high-risk features, the American Academy of Pediatrics recommends initiating empiric broad-spectrum antibiotics, with first-line treatment being an antipseudomonal β-lactam or carbapenem 6, 9

For low-risk patients, the Journal of Clinical Oncology recommends discontinuing antibiotics at 48-72 hours if blood cultures are negative, the patient is afebrile for ≥24 hours, and marrow recovery status is ensured 8, 6
The American Academy of Pediatrics recommends avoiding broad-spectrum agents without specific indication and reserving them for documented serious infections with resistant pathogens or critically ill patients 9
For children with persistent fever beyond 10 days despite negative initial workup, the American Academy of Pediatrics recommends repeat thorough history and physical examination, assessment for accompanying symptoms, and consideration of subspecialty consultation 7